Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.
- Website
- gilgameshpharmaceutical.com
- City
- New York City
- Country
- United States
- YC batch
- Summer 2020
- Team
- 15 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in New York City
Ro$5bn
Health technology. Valued at $5bn (March 2021).
Noom$3.7bn
Healthcare. Valued at $3.7bn (May 2021).
Headway$2.3bn
Healthcare. Valued at $2.3bn (July 2024).
Sword Health$2bn
Health. Valued at $2bn (November 2021).
H1
Connecting stakeholders across the healthcare ecosystem.
Opentrons
We make robots for biologists.
Claim this profile
Free and instant: prove you run gilgameshpharmaceutical.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Gilgamesh Pharmaceuticals across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Gilgamesh Pharmaceuticals's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
